This story originally ran on Feb. 11.
AB Sciex mass spectrometers will be used to test for performance-enhancing drug use by athletes during the 2010 Winter Olympics, the company said this week.
Canada’s Institut Armand-Frappier, part of the country’s Institut National de la Recherché Scientifique, has created an $8.9 million testing facility to test for sports doping during the competition, which begins in Vancouver, BC, this weekend. As part of that effort, AB Sciex’s 4000 QTrap systems will be used to detect for stimulants, masking agents, glucocorticosteroids, and insulin.
Four of the LC-MS/MS platforms will be deployed, the company said in a statement.
Laura Lauman, a president of AB Sciex, said the agreement “is a great example of how mass spectrometry is increasingly being used to address a variety of scientific challenges beyond the research lab.”
AB Sciex, formed earlier this month from the former Applied Biosystems/MDS Analytical Technologies mass spec joint venture, operates within Danaher [see PM 02/05/10].